Vividion Therapeutics
- Active openings
- 3
- US-based roles
- 0
- Remote-friendly
- 0
- Last updated
- 2026-10-06
What Vividion Therapeutics is hiring for
Open positions
3 active- Associate Director/Director/Senior Director, Clinical BiomarkersOct 6
- Associate Scientist, Preformulation Sciences (Contractor)Oct 3
- Senior Associate Scientist, Translational Research (Contractor)Oct 3
About Vividion Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase 2 Combination Study in First-Line Patients with Advanced Colorectal Cancer
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial
Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer
Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
Vividion Publishes Discovery of WRN Inhibitor VVD-214 in Journal of Medicinal Chemistry